Anbio Biotechnology (NNNN) Other Accumulated Expenses (2023 - 2024)
Historic Other Accumulated Expenses for Anbio Biotechnology (NNNN) over the last 2 years, with Q4 2024 value amounting to $104979.0.
- Anbio Biotechnology's Other Accumulated Expenses fell 3672.5% to $104979.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $104979.0, marking a year-over-year decrease of 3672.5%. This contributed to the annual value of $104979.0 for FY2024, which is 3672.5% down from last year.
- Per Anbio Biotechnology's latest filing, its Other Accumulated Expenses stood at $104979.0 for Q4 2024, which was down 3672.5% from $165909.0 recorded in Q4 2023.
- In the past 5 years, Anbio Biotechnology's Other Accumulated Expenses ranged from a high of $165909.0 in Q4 2023 and a low of $104979.0 during Q4 2024